Annual Report And Accounts

Overview

The report highlights Oxford Biomedica's strong 2018 commercial performance, including a 78% increase in revenue to £66.8 million and the commercial progress of its gene and cell therapy partnerships. The company expanded its workforce from 321 to 432 employees while investing in new manufacturing and discovery facilities to meet demand. Its corporate responsibility disclosures cover employee safety and diversity, community engagement, environmental management, emissions, waste and ethical conduct.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2018
Period: Ends 31 December 2018
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services